Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
- PMID: 26476479
- DOI: 10.1016/j.jaci.2015.08.034
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Abstract
Cutaneous lesions in patients with mastocytosis are highly heterogeneous and encompass localized and disseminated forms. Although a classification and criteria for cutaneous mastocytosis (CM) have been proposed, there remains a need to better define subforms of cutaneous manifestations in patients with mastocytosis. To address this unmet need, an international task force involving experts from different organizations (including the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology) met several times between 2010 and 2014 to discuss the classification and criteria for diagnosis of cutaneous manifestations in patients with mastocytosis. This article provides the major outcomes of these meetings and a proposal for a revised definition and criteria. In particular, we recommend that the typical maculopapular cutaneous lesions (urticaria pigmentosa) should be subdivided into 2 variants, namely a monomorphic variant with small maculopapular lesions, which is typically seen in adult patients, and a polymorphic variant with larger lesions of variable size and shape, which is typically seen in pediatric patients. Clinical observations suggest that the monomorphic variant, if it develops in children, often persists into adulthood, whereas the polymorphic variant may resolve around puberty. This delineation might have important prognostic implications, and its implementation in diagnostic algorithms and future mastocytosis classifications is recommended. Refinements are also suggested for the diagnostic criteria of CM, removal of telangiectasia macularis eruptiva perstans from the current classification of CM, and removal of the adjunct solitary from the term solitary mastocytoma.
Keywords: Classification; cutaneous mastocytosis; diagnostic criteria; mast cell; mastocytosis; standardization; urticaria pigmentosa.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Cutaneous mastocytosis: a review focusing on the pediatric population.Clin Pediatr (Phila). 2008 Oct;47(8):757-61. doi: 10.1177/0009922808318344. Epub 2008 May 23. Clin Pediatr (Phila). 2008. PMID: 18502981 Review.
-
Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors.Immunol Allergy Clin North Am. 2018 Aug;38(3):351-363. doi: 10.1016/j.iac.2018.04.001. Epub 2018 May 17. Immunol Allergy Clin North Am. 2018. PMID: 30007456 Review.
-
[Cutaneous Manifestations in Mastocytosis: Update].Acta Med Port. 2020 Apr 1;33(4):275-281. doi: 10.20344/amp.12189. Epub 2020 Apr 1. Acta Med Port. 2020. PMID: 32238242 Review. Portuguese.
-
Telangiectasia macularis eruptiva perstans: an old terminology, still frequently used.Dermatol Online J. 2017 Aug 15;23(8):13030/qt6zx243zm. Dermatol Online J. 2017. PMID: 29469737 Review.
-
Dermatoscopic findings of cutaneous mastocytosis.Dermatology. 2009;218(3):226-30. doi: 10.1159/000182260. Epub 2008 Dec 6. Dermatology. 2009. PMID: 19060465
Cited by
-
Mastocytosis: One Word for Different Diseases.Oncol Ther. 2018 Dec;6(2):129-140. doi: 10.1007/s40487-018-0086-2. Epub 2018 Oct 29. Oncol Ther. 2018. PMID: 32700030 Free PMC article. Review.
-
Beyond Midostaurin: Role of Avapritinib in Managing Systemic Mastocytosis.Cureus. 2024 May 12;16(5):e60161. doi: 10.7759/cureus.60161. eCollection 2024 May. Cureus. 2024. PMID: 38868249 Free PMC article.
-
Intertriginous maculopapular mastocytosis in a patient with acute myeloid leukemia.JAAD Case Rep. 2017 Feb 3;3(1):61-63. doi: 10.1016/j.jdcr.2016.11.004. eCollection 2017 Jan. JAAD Case Rep. 2017. PMID: 28229121 Free PMC article. No abstract available.
-
Maculopapular Cutaneous Mastocytosis in a Diverse Population.J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2845-2847. doi: 10.1016/j.jaip.2019.04.003. Epub 2019 May 2. J Allergy Clin Immunol Pract. 2019. PMID: 31056447 Free PMC article. No abstract available.
-
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions.J Allergy Clin Immunol. 2020 Aug;146(2):300-306. doi: 10.1016/j.jaci.2020.06.009. Epub 2020 Jun 17. J Allergy Clin Immunol. 2020. PMID: 32561389 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous